Viewing Study NCT04830202


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-26 @ 2:23 AM
Study NCT ID: NCT04830202
Status: AVAILABLE
Last Update Posted: 2025-10-03
First Post: 2021-03-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access to Telisotuzumab Vedotin
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module